Published in J Mol Cell Cardiol on December 01, 2002
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J (2004) 1.98
Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol (2009) 1.46
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension (2010) 1.04
Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors. Hypertension (2005) 0.83
Proteomic characterization of serine hydrolase activity and composition in normal urine. Clin Proteomics (2013) 0.81
Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling. Int J Hypertens (2012) 0.78
Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest (2009) 2.02
Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res (2006) 1.92
Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability. J Cell Biol (2011) 1.10
Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J Mol Biol (2004) 1.09
Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol Pharmacol (2004) 1.09
Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745. J Biol Chem (2007) 1.07
Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation (2002) 1.06
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension (2010) 1.04
Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am J Pathol (2010) 1.04
Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem (2002) 1.02
Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension (2002) 1.00
Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists. J Biol Chem (2008) 0.97
Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. Am J Physiol Heart Circ Physiol (2003) 0.95
Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. J Immunol (2002) 0.95
Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J (2006) 0.93
Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am J Physiol Heart Circ Physiol (2005) 0.89
Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol (2002) 0.89
Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium. J Biol Chem (2012) 0.87
Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling. J Biol Chem (2011) 0.85
Beta-arrestin 2 is required for B1 receptor-dependent post-translational activation of inducible nitric oxide synthase. FASEB J (2010) 0.84
Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells. J Pharmacol Exp Ther (2005) 0.84
Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release. Am J Physiol Heart Circ Physiol (2005) 0.83
Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 0.83
Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor. Hypertension (2002) 0.83
Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors. Hypertension (2005) 0.83
Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J Mol Biol (2006) 0.83
Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane. Int Immunopharmacol (2002) 0.82
The ectodomain shedding of angiotensin-converting enzyme is independent of its localisation in lipid rafts. J Cell Sci (2003) 0.81
Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process. Am J Physiol Heart Circ Physiol (2009) 0.81
Carboxypeptidase M is a positive allosteric modulator of the kinin B1 receptor. J Biol Chem (2013) 0.79
Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output. Biol Chem (2013) 0.77
Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats. Peptides (2002) 0.77
Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N. Biochem J (2005) 0.76
The kinin system: suggestions to broaden some prevailing concepts. Int Immunopharmacol (2002) 0.76
Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors. Cell Signal (2012) 0.76
B2R of bradykinin activated by proteases. Hypertension (2003) 0.75
Effect of angiotensin-converting-enzyme inhibitors. Lancet (2002) 0.75